List of Excipients in API chlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing chlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | ALCOHOL | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | BENZOIC ACID | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | D&C YELLOW NO. 10 | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | GLYCERIN | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | METHYLPARABEN | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | PROPYLPARABEN | |
| Salix Pharmaceuticals Inc | DIURIL | chlorothiazide | 65649-311 | SUCROSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing chlorothiazide
Detailed excipient profiles for chlorothiazide
Excipient focus: ALCOHOL
chlorothiazide drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing ALCOHOL
Excipient focus: BENZOIC ACID
chlorothiazide drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing BENZOIC ACID
Excipient focus: D&C YELLOW NO. 10
chlorothiazide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: GLYCERIN
chlorothiazide drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing GLYCERIN
Excipient focus: MANNITOL
chlorothiazide drug variants containing MANNITOL
chlorothiazide drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
chlorothiazide drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing METHYLPARABEN
Excipient focus: PROPYLPARABEN
chlorothiazide drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM HYDROXIDE
chlorothiazide drug variants containing SODIUM HYDROXIDE
chlorothiazide drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
chlorothiazide drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing SUCROSE
Excipient focus: TRAGACANTH
chlorothiazide drug variants containing TRAGACANTH
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing TRAGACANTH
Excipient focus: WATER
chlorothiazide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | chlorothiazide | 65649-311 |
| >Company | >Ingredient | >NDC |
chlorothiazide drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
